JP3074410B2 - Osteosynthesis device - Google Patents

Osteosynthesis device

Info

Publication number
JP3074410B2
JP3074410B2 JP03341894A JP34189491A JP3074410B2 JP 3074410 B2 JP3074410 B2 JP 3074410B2 JP 03341894 A JP03341894 A JP 03341894A JP 34189491 A JP34189491 A JP 34189491A JP 3074410 B2 JP3074410 B2 JP 3074410B2
Authority
JP
Japan
Prior art keywords
plla
core material
pla
bone
ceramic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP03341894A
Other languages
Japanese (ja)
Other versions
JPH05146501A (en
Inventor
保夫 敷波
邦広 畑
英和 棒谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takiron Co Ltd
Original Assignee
Takiron Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takiron Co Ltd filed Critical Takiron Co Ltd
Priority to JP03341894A priority Critical patent/JP3074410B2/en
Publication of JPH05146501A publication Critical patent/JPH05146501A/en
Application granted granted Critical
Publication of JP3074410B2 publication Critical patent/JP3074410B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/84Fasteners therefor or fasteners being internal fixation devices
    • A61B17/86Pins or screws or threaded wires; nuts therefor
    • A61B17/866Material or manufacture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、骨の損傷や骨折時ある
いは骨移植時に、骨が形成されるまでその部分を固定、
補助および補綴する骨接合用デバイスに関する。更に詳
しくは、芯材として生体骨と同等の組成を有する酸化物
系セラミックスまたは燐酸カルシウム系セラミックスの
成形体を使用し、これを生体内吸収性のポリ乳酸で被覆
した骨接合用デバイスに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is to fix a portion of a bone until it is formed at the time of bone damage, fracture or bone transplantation.
Auxiliary and prosthetic osteosynthesis devices. More specifically, the present invention relates to an osteosynthesis device in which a molded body of an oxide ceramic or a calcium phosphate ceramic having a composition equivalent to that of a living bone is used as a core material and the molded body is covered with a bioabsorbable polylactic acid.

【0002】[0002]

【従来の技術】整形外科、形成外科、胸部外科、口腔外
科等の外科分野では、生体骨の固定、接合を目的とした
人工整復材として、従来より金属製(Cr−Ni合金
系、Ti合金系など)とセラミックス製(アルミナ,ジ
ルコニアなどの酸化物系セラミックスや、ハイドロキシ
アパタイト、燐酸三カルシウムなどの燐酸カルシウム系
セラミックスなど)の無機材料が使用されるようになっ
ている。
2. Description of the Related Art In surgical fields such as orthopedic surgery, plastic surgery, thoracic surgery, and oral surgery, metal (Cr-Ni alloy, Ti alloy) has been conventionally used as an artificial reduction material for fixing and joining living bone. And inorganic materials made of ceramics (such as oxide ceramics such as alumina and zirconia and calcium phosphate ceramics such as hydroxyapatite and tricalcium phosphate).

【0003】また最近では、ポリ乳酸、ポリグリコール
酸、ポリジオキサノン或はこれらの共重合体からなる生
体内分解吸収性材料を用いた整復材に関する研究も盛ん
で、臨床試験の段階を経て実用化されつつある。
[0003] Recently, studies on reduction materials using biodegradable and absorbable materials composed of polylactic acid, polyglycolic acid, polydioxanone or copolymers thereof have been actively conducted, and have been put into practical use through clinical trial stages. It is getting.

【0004】[0004]

【発明が解決しようとする課題】上記の金属製材料は長
期の実績があり、よく用いられているが、弾性率が非常
に高いため周囲骨の強度を低下させたり、また金属イオ
ンの溶出によって生体を損傷する可能性があるなどの問
題点を有している。更に、金属製材料の最大の欠点は、
骨折や骨の損傷が治癒した時点で、それを生体内から取
り出すために再手術をしなければならず、そのことが患
者に肉体的、経済的な負担を強いる点にある。
The above-mentioned metallic materials have a long track record and are often used. However, since the elastic modulus is very high, the strength of the surrounding bone is reduced, and the metal ions are eluted. There is a problem that the living body may be damaged. Furthermore, the biggest disadvantage of metallic materials is that
Once a fracture or bone damage has healed, it must be re-operated to remove it from the body, placing a physical and economic burden on the patient.

【0005】一方、セラミックス製材料は、生体適合性
が良好なことから、近年盛んに試用されているが、これ
らもまた金属製材料と同様に弾性率が高いことに起因す
る弊害を問題点として残している。また、セラミックス
製材料は他の材料と比較して脆いという点にも問題があ
る。
On the other hand, ceramic materials have been actively used in recent years because of their good biocompatibility. However, these materials also suffer from the disadvantages caused by their high elastic modulus similarly to metal materials. Have left. There is also a problem in that ceramic materials are brittle compared to other materials.

【0006】このような骨接合用デバイスとして、近
年、生体吸収性高分子を用いる研究が盛んであり、特に
ポリ乳酸、ポリグリコール酸、グリコール−乳酸コポリ
マーを成形することにより骨接合用デバイスを得るとい
う研究が多く、特開昭59−97654号、特開平1−
198552号、特開平1−198553号、特開平3
−29663号、特開平3−103429号などはその
例である。なかでも、本発明者らは、特開平1−198
553号において、粘度平均分子量が30万以上のポリ
乳酸を成形し、その後延伸操作を加えることにより、初
期強度及び初期弾性率が生体骨と同程度で、且つ骨折及
び損傷を受けた骨の強度と機能がほぼ回復するまでの
間、生体骨に近い強度を維持しており、最終的に骨の形
成が完了する頃には、生体内に完全に吸収されていると
いう理想的な骨接合材を提供した。更に本発明者らは、
特開平3−29663号において、生体の各部位におけ
る骨の必要強度と強度保持期間を明確にし、各部位に好
適に使用される骨接合材を提供した。
In recent years, studies using bioabsorbable polymers have been actively conducted as such osteosynthesis devices. In particular, osteosynthesis devices are obtained by molding polylactic acid, polyglycolic acid, and glycol-lactic acid copolymer. There are many studies, such as JP-A-59-97654,
198552, JP-A-1-198553, JP-A-3
JP-A-29663 and JP-A-3-103429 are examples thereof. In particular, the present inventors have disclosed Japanese Patent Application Laid-Open No. 1-198.
No. 553, a polylactic acid having a viscosity average molecular weight of 300,000 or more is molded, and then subjected to a stretching operation, whereby the initial strength and the initial elastic modulus are almost the same as those of a living bone, and the strength of a fractured or damaged bone. An ideal osteosynthesis material that maintains strength close to that of living bone until its function is almost restored, and is completely absorbed into the body by the time bone formation is finally completed. Offered. Furthermore, the present inventors
In JP-A-3-29663, the required strength of bone and the strength maintaining period in each part of a living body are clarified, and an osteosynthesis material suitably used for each part is provided.

【0007】本発明者らが提供したこれらの骨接合材
は、強度的には骨接合材として要求される特性を全て満
たしており、現在に至っても問題点のない優れた材料で
ある。しかし、一方で、ポリ乳酸からなる径の太いスク
リュー等を用いた場合には、その吸収速度がスローであ
り、完全に吸収されるまでに1〜2年、場合によっては
3年程度かかるものがあることが判ってきた。
[0007] These osteosynthesis materials provided by the present inventors satisfies all of the properties required for an osteosynthesis material in terms of strength, and are excellent materials which have no problems up to the present. However, on the other hand, when a thick screw made of polylactic acid or the like is used, the absorption speed is slow, and it takes about 1 to 2 years, or about 3 years in some cases, until it is completely absorbed. I have found something.

【0008】また、生体吸収性材料を用いた複合体の研
究も行われており、特開昭63−68155号ではポリ
乳酸にハイドロキシアパタイトを混合し、溶融押出によ
り成形したピン状成形物が開示されている。しかし、こ
の場合には吸収性材料の部分が分解吸収されるにつれて
ポーラスな構造になり、ある時点でより加速度的に分
解吸収が促進される傾向が不可避である。そのため、局
部的にPHが下降し、炎症を起こす可能性が大きい。
[0008] In addition, a composite using a bioabsorbable material has been studied, and JP-A-63-68155 discloses a pin-shaped molded product obtained by mixing hydroxyapatite with polylactic acid and molding by melt extrusion. Have been. However, in this case, as the portion of the absorbent material is decomposed and absorbed, the structure becomes porous, and at some point, the tendency of accelerated decomposition and absorption is inevitable. Therefore, there is a high possibility that the PH locally decreases and inflammation occurs.

【0009】更に、USP4743257号において
は、生体吸収性高分子からなるマトリックスを同じ成分
からなるファイバーで補強する所謂self−rein
forceした複合体からなる骨接合材が示されている
が、これも繊維状にほぐれて表面積が大きくなるので、
ある時期に急激にバースト的吸収を起こす可能性が大き
く、それにより炎症を引き起こす場合が考えられる。
Further, in US Pat. No. 4,743,257, a so-called self-rein in which a matrix made of a bioabsorbable polymer is reinforced with a fiber made of the same component.
Bone bonding material composed of a forced composite is shown, but this is also loosened in a fibrous form and the surface area increases.
It is highly likely that a burst of absorption will occur at a certain time, thereby causing inflammation.

【0010】本発明は上記のような問題点に鑑みてなさ
れたもので、初期強度、初期弾性率に優れ、生体内に埋
入後数ケ月程度で周囲のポリ乳酸の被覆部分が吸収さ
れ、その後はセラミックスの芯材が生体組織と適合する
ため、抜釘のための再手術の必要性がなく、また生体吸
収性のポリ乳酸の占める割合が低いため、吸収される絶
対量が少なく、炎症を引き起こす可能性が極めて低く、
新生骨により吸収された後の空洞が早期に埋まるという
理想的な骨接合用デバイスを提供することを目的とす
る。
The present invention has been made in view of the above-mentioned problems, and has excellent initial strength and initial elastic modulus, and the surrounding polylactic acid-coated portion is absorbed several months after implantation in a living body, After that, since the ceramic core material is compatible with the living tissue, there is no need for re-operation for nail removal, and since the ratio of bioabsorbable polylactic acid is low, the absolute amount absorbed is small, causing inflammation. Very unlikely to cause
It is an object of the present invention to provide an ideal osteosynthesis device in which a cavity after being absorbed by new bone is buried early.

【0011】[0011]

【課題を解決するための手段】本発明き骨接合用デバイ
スは、酸化物系セラミックスまたは燐酸カルシウム系セ
ラミックスの成形体を芯材とし、該芯材を一軸延伸され
たポリ乳酸で被覆したことを特徴とする。
The bone bonding device according to the present invention is characterized in that a molded body of an oxide-based ceramic or a calcium phosphate-based ceramic is used as a core material, and the core material is coated with uniaxially stretched polylactic acid. Features.

【0012】本発明に用いる芯材は、酸化物系セラミッ
クスまたは燐酸カルシウム系セラミックスの成形体で生
体適合性の良いものであればよく、例えば酸化物系セラ
ミックスとしてはアルミナ、ジルコニアなどが、燐酸カ
ルシウム系セラミックスとしてはハイドロキシアパタイ
ト、燐酸三カルシウムなどが好ましく使用される。これ
らのセラミックス材料は、従来法によって成形した後、
所定の外径を有する円柱状に精密加工して用いればよ
い。尚、これらのセラミックスの他に生体活性のある脱
灰骨を充填したり、BMP(Bone Morphor
ogeneticProtein)を混合して用いても
よい。
The core material used in the present invention may be a molded body of an oxide ceramic or a calcium phosphate ceramic having good biocompatibility. For example, alumina and zirconia may be used as the oxide ceramic. Hydroxyapatite, tricalcium phosphate and the like are preferably used as the base ceramics. After forming these ceramic materials by the conventional method,
What is necessary is just to precision-process and use it in the column shape which has a predetermined outer diameter. In addition to these ceramics, bioactive demineralized bone can be filled, or BMP (Bone Morphor) can be used.
organic protein).

【0013】一方、被覆材として使用する生体内吸収性
のポリ乳酸(以下、PLAと記す)は、光学活性を有す
るL体またはD体の乳酸から常法(C.E.Love,
米国特許第2668182号明細書)に従って乳酸の環
状二量体であるラクチドを合成したあと、そのラクチド
を開環重合することによって得られるもので、L体のポ
リ乳酸(以下、PLLAと記す)の方がより好適であ
る。このPLLAは、分子量と結晶化度を適度に調整す
ることが重要である。即ち、PLLAは分子量が高いも
のほど高強度の材料となるが、あまり分子量が高すぎる
と、溶融成形の際に高温、高圧が必要となるため大幅な
分子量低下を招き、結果として溶融成形後の分子量は低
いものとなり、当然のことながら強度も低いものとな
る。他方、結晶性材料は非晶性材料に比べて曲げ強度、
弾性率が高く、また体液の浸透は結晶相の方が遅く、見
掛け上の加水分解も遅い。しかし、熱処理により結晶化
度を上げていくと、強度は向上するが、PLLAが熱的
に不安定であるため劣化が進行して分子量低下が生じ、
加水分解速度が速くなり、強度劣化が急激に起こるよう
になる。このような理由から、被覆材料のPLLAは粘
度平均分子量が30万〜60万、なかんずく35万〜5
5万程度で、結晶化度が10〜60%程度のものが好適
に使用される。
On the other hand, bioabsorbable polylactic acid (hereinafter, referred to as PLA) used as a coating material is prepared from optically active L-form or D-form lactic acid by a conventional method (CE Love,
It is obtained by synthesizing lactide which is a cyclic dimer of lactic acid according to U.S. Pat. No. 2,668,182), and subjecting the lactide to ring-opening polymerization, which is an L-form polylactic acid (hereinafter, referred to as PLLA). Is more preferred. It is important for the PLLA to appropriately adjust the molecular weight and the crystallinity. That is, the higher the molecular weight of PLLA, the higher the strength of the material. However, if the molecular weight is too high, a high temperature and a high pressure are required during melt molding, so that a significant decrease in the molecular weight is caused. The molecular weight is low and, of course, the strength is low. On the other hand, crystalline materials have higher flexural strength than amorphous materials,
The elastic modulus is high, and the penetration of body fluids is slower in the crystalline phase and the apparent hydrolysis is slower. However, when the degree of crystallinity is increased by heat treatment, the strength is improved, but because PLLA is thermally unstable, the deterioration proceeds and the molecular weight decreases,
The hydrolysis rate is increased, and the strength is rapidly deteriorated. For this reason, the PLLA of the coating material has a viscosity average molecular weight of 300,000 to 600,000, preferably 350,000 to 5
Those having a crystallinity of about 50,000 and about 10 to 60% are preferably used.

【0014】また、被覆材料のPLLAは、溶融成形後
に一軸延伸するなどの公知の延伸方法を採用して2〜5
倍程度の延伸倍率で一軸延伸することが望ましい。この
ように一軸延伸するとPLLA成形物の強度が向上し、
圧縮曲げ強度が160〜250MPa、圧縮曲げ弾性率
が5500〜24000MPaの値を示す強靭なものと
なり、また、延伸後の若干の戻りが生じることによって
芯材を締付ける力が大幅に増大するからである。
The PLLA of the coating material may be formed by a known stretching method such as uniaxial stretching after melt molding.
It is desirable that the film is uniaxially stretched at a draw ratio of about twice. The uniaxial stretching increases the strength of the PLLA molded product,
This is because the compression bending strength is 160 to 250 MPa, and the compression bending elastic modulus is tough to show a value of 5500 to 24000 MPa, and a slight return after stretching causes a large increase in the force for tightening the core material. .

【0015】上記の如き延伸されたPLLA被覆材で前
記のセラミックス芯材を被覆した本発明の骨接合用デバ
イスは、一般的な外科手術で用いられているようなロッ
ド、スクリュー、ピンなど種々の形状で利用される。ロ
ッドやピンの場合は芯材の直径を1〜3.5mm(好ま
しくは1.2〜3mm)程度、PLLA被覆材の厚みを
0.75〜2mm(好ましくは1〜1.5mm)程度、
全体の直径を2.5〜8mm(好ましくは3〜6mm)
程度に設定したものが使用され、またスクリューの場合
もほぼ同寸法のものが使用されるが、スクリューのPL
LA被覆材の厚みは溝切り分を考慮してやや厚くするの
が望ましい。
The osteosynthesis device of the present invention in which the above-mentioned ceramic core is coated with the stretched PLLA coating material as described above can be used for various rods, screws, pins and the like used in general surgical operations. Used in shapes. In the case of a rod or a pin, the diameter of the core material is about 1 to 3.5 mm (preferably 1.2 to 3 mm), the thickness of the PLLA coating material is about 0.75 to 2 mm (preferably 1 to 1.5 mm),
2.5-8mm (preferably 3-6mm) overall diameter
About the same size is used for the screw, but the screw PL
It is desirable that the thickness of the LA coating material is made slightly thicker in consideration of the groove cut.

【0016】本発明の骨接合用デバイスは、例えばPL
A(PLLA)を溶融成形し、望ましくは一軸延伸した
後、ドリル加工により孔をあけて中空パイプとし、これ
を窒素雰囲気中80℃前後で加熱した状態で芯材を孔に
挿入することにより製造される。この際、ドリル加工で
発生する熱がPLLAに蓄熱しないように注意すること
が肝要である。尚、上記の製造方法は一例であり、これ
以外にも、例えばクロスヘッド金型を用いて芯材にPL
Aを被覆する方法など、種々の製造方法が採用可能であ
る。
The osteosynthesis device of the present invention is, for example, PL
A (PLLA) is melt molded, desirably uniaxially stretched, then drilled to form a hollow pipe into a hollow pipe, which is heated at about 80 ° C. in a nitrogen atmosphere, and the core material is inserted into the hole. Is done. At this time, it is important to take care that heat generated by drilling does not accumulate in the PLLA. The above manufacturing method is merely an example. In addition to this, for example, a PL is applied to the core material using a crosshead mold.
Various manufacturing methods such as a method of coating A can be adopted.

【0017】[0017]

【作用】本発明の骨接合用デバイスを体内に埋入する
と、表面のPLA(PLLA)が体液と接触して徐々に
加水分解を始め、表面から内側に穏やかに進行するが、
本発明のデバイスはPLAを被覆材部分にのみ用いてい
るため、全体をPLAで成形した従来のデバイスに比較
すると、PLAの吸収が早期に完了し、吸収される絶対
量も少ない。従って、本発明の骨接合用デバイスは炎症
を起こす可能性が極めて低い。そして、PLAの被覆材
が完全に吸収された後には生体適合性に優れたハイドロ
キシアパタイト等のセラミックスの芯材が残り、骨折部
分や損傷部分が完全に治癒するまでの間、骨接合用デバ
イスとしての機能を果たす。
When the osteosynthesis device of the present invention is implanted in the body, the surface PLA (PLLA) comes into contact with bodily fluids and gradually begins to hydrolyze, gently progressing from the surface to the inside.
Since the device of the present invention uses PLA only for the coating material portion, the absorption of PLA is completed earlier and the absolute amount absorbed is smaller than that of a conventional device formed entirely of PLA. Therefore, the osteosynthesis device of the present invention has a very low possibility of causing inflammation. After the PLA coating material is completely absorbed, a ceramic core material such as hydroxyapatite, which is excellent in biocompatibility, remains, and is used as an osteosynthesis device until the fracture or damaged part is completely healed. Perform the function of

【0018】このように本発明の骨接合用デバイスは、
PLA製デバイスに比べると、PLAの吸収速度が速く
吸収される絶対量が少ないため、炎症を起こしにくいも
のであり、しかも、セラミックス製の芯材をPLLAで
被覆しているため、従来のセラミックス製デバイスに見
られるような脆さの欠点を充分カバーできるものであ
る。つまり初期強度がPLAと芯材の中間的な値を示
し、その表面特性はPLAの性質に依存する。PLAは
有機ポリマーとしての靱性を与え、芯材であるセラミッ
クスは弾性率の高さと剛性が強いことの利点を与える。
芯材に用いるセラミックスの粉体を混合した場合には、
このような物理的強度は改善されない。
As described above, the osteosynthesis device of the present invention comprises:
Compared with PLA devices, PLA has a higher absorption rate and a smaller absolute amount is absorbed, so that it is less likely to cause inflammation. Moreover, since the ceramic core material is covered with PLLA, the conventional ceramic material is used. It can sufficiently cover the disadvantages of brittleness found in devices. That is, the initial strength shows an intermediate value between PLA and the core material, and the surface characteristics depend on the properties of PLA. PLA provides toughness as an organic polymer, and ceramics as a core material has advantages of high elastic modulus and high rigidity.
When the ceramic powder used for the core material is mixed,
Such physical strength is not improved.

【0019】また、PLAが完全に吸収された時には、
骨折及び損傷部位の治癒がある程度進行しており、セラ
ミックス材料の欠点である周囲骨の強度低下の現象も最
小限に抑えることができる。更に、PLAにハイドロキ
シアパタイトを粉末あるいはフレーク状で混合したり、
繊維補強したものと比較しても、バースト状の吸収がな
く、炎症を起こす可能性が低いなど、現在使用あるいは
検討されている骨接合デバイスに比べても極めて優れた
骨接合用デバイスであると言える。
When PLA is completely absorbed,
Healing of fractures and injured parts has progressed to some extent, and the phenomenon of a decrease in the strength of the surrounding bone, which is a defect of the ceramic material, can be minimized. Furthermore, mixing hydroxyapatite with PLA in powder or flake form,
Compared to fiber reinforced devices, there is no burst-like absorption, and the possibility of inflammation is low, and it is an extremely superior osteosynthesis device compared to currently used or studied osteosynthesis devices I can say.

【0020】また、本発明者らは、被覆材として好適に
使用されるPLAを延伸すると圧電性を生じるという事
実を見出した。この圧電性の効果により仮骨の生成が促
進されることが判っており、その点からも本発明の骨接
合用デバイスは理想的なものと言える。
The present inventors have also found out that PLA, which is preferably used as a coating material, has piezoelectricity when stretched. It has been found that the generation of callus is promoted by this piezoelectric effect, and from that point, the osteosynthesis device of the present invention can be said to be ideal.

【0021】更に、PLAからなる従来のデバイスはX
線によるレントゲン撮影には写らないという欠点があ
り、埋入後の分解挙動などを把握しにくいという問題が
あったが、本発明の骨接合用デバイスでは、芯材として
用いるセラミックス系成形物がX線撮影可能であり、レ
ントゲン撮影時のマーカーにもなり得る。
Further, a conventional device made of PLA is X
X-rays with X-rays have the drawback that they are not captured, and there is a problem that it is difficult to grasp the decomposition behavior and the like after implantation. However, in the osteosynthesis device of the present invention, the ceramic molding used as the core material is X X-rays can be taken and can be used as markers during X-ray photography.

【0022】[0022]

【実施例】以下、本発明の実施例を詳述する。Embodiments of the present invention will be described below in detail.

【0023】直径1.5mmのハイドロキシアパタイト
(以下、HAと記す)の焼結ロッドに対し、粘度平均分
子量(クロロホルム中、25℃にて測定)が40万のP
LLAを押出成形により被覆してHA/PLLAの複合
ロッドを作り、次いで105℃の温度でPLLAの被覆
部分を長軸方向に4倍に延伸することにより、外径が
3.2mm,長さ5.5cmの複合ロッドを作製した
(サンプル1)。
A hydroxyapatite (hereinafter referred to as HA) sintered rod having a diameter of 1.5 mm has a viscosity average molecular weight (measured in chloroform at 25 ° C.) of 400,000 P
The LLA is coated by extrusion to form a composite rod of HA / PLLA, and then the coated portion of PLLA is stretched four times in the longitudinal direction at a temperature of 105 ° C., so that the outer diameter is 3.2 mm and the length is 5 mm. A composite rod of 0.5 cm was prepared (Sample 1).

【0024】また、同様の方法で、HA及びウォラスト
ナイトを含有する結晶化ガラスよりなる直径2mmのロ
ッドをPLLAで被覆して、外径6.5mm長さ5cm
の複合ロッドを作り、これを切削加工して海綿骨用スク
リュー(スクリューの谷径は4mm、PLLAの肉厚は
谷径の部分で1mm、山径の部分で2.25mm)を作
製した(サンプル2)。
In the same manner, a rod made of crystallized glass containing HA and wollastonite having a diameter of 2 mm is coated with PLLA, and the outer diameter is 6.5 mm and the length is 5 cm.
Was prepared and cut into a cancellous bone screw (screw trough diameter 4 mm, PLLA wall thickness 1 mm at trough diameter portion, 2.25 mm at crest diameter portion) (sample 2).

【0025】これらの物理的強度を測定したところ、曲
げ強度及び曲げ弾性率は芯材が支配的であり、サンプル
1でそれぞれ2400kg/cm2と2100kg/m
2、サンプル2でそれぞれ2500kg/cm2と40
00kg/mm2であった。また、表面はPLLAの物
性に依存し、セラミックスの脆さはなく、靱性を有して
いた。しかも、PLLAのような可撓性はなく、芯材の
セラミックスの剛性を有しているので、スクリューを埋
入するに都合のよい強度を有していた。また、芯材とP
LLA被覆材の界面は、PLLAの延伸時に一度伸長し
た後、加熱下に戻りが生じて芯材を締め付けた状態が生
ずるので、単にセラミックスロッドを熱被覆した状態と
は異なっており、物理的な密着が非常に強く、容易に剥
離できるものではなかった。これは密着力を上げるため
に接着剤として第三物質を要しないので好都合であっ
た。
When these physical strengths were measured, the bending strength and the flexural modulus were dominated by the core material, and Sample 1 had 2400 kg / cm 2 and 2100 kg / m 2 , respectively.
m 2 , 2500 kg / cm 2 and 40 for sample 2, respectively
It was 00 kg / mm 2 . Further, the surface was dependent on the physical properties of PLLA, and the ceramic had no brittleness and had toughness. In addition, since it does not have the flexibility of PLLA and has the rigidity of the ceramics of the core material, it has a strength that is convenient for inserting the screw. Also, the core material and P
The interface of the LLA coating material is different from the state in which the ceramic rod is simply heat-coated because the interface is once heated at the time of elongating the PLLA and then returned under heating to tighten the core material. The adhesion was so strong that it could not be easily peeled off. This was advantageous because no third material was required as an adhesive to increase the adhesion.

【0026】次いで、サンプル1のロッドを、5頭のネ
コの脛・腓骨骨幹部中央を実験的に横骨折を作り、その
髄内に挿入して整復、固定した。外部は硬化帯を装着
し、各固体ともにケージレストを行った。
Next, the rod of the sample 1 was experimentally created with a transverse fracture at the center of the shin / fibula shaft of five cats, inserted into the medulla thereof, and reduced and fixed. The outside was equipped with a hardening zone, and each solid was cage-rested.

【0027】一方、サンプル2のスクリューは5羽の家
兎の脛骨近位部に実験的に骨切り術を行い、内固定し
た。即ち、体重約3kgの家兎の右脛骨近位部に関節面
約1/3を含む縦割れ骨折を作成し、スクリュー一本に
て内固定した。外固定はせずケージレストを行った。
On the other hand, the screw of Sample 2 was experimentally osteotomized in the proximal part of the tibia of five rabbits and fixed internally. That is, a vertically fractured fracture including about one-third of the joint surface was created in the proximal part of the right tibia of a rabbit weighing about 3 kg, and internally fixed with a single screw. Cage rest was performed without external fixation.

【0028】両者のコントロールとしてPLLAのみか
らなる同径、同長のロッドとスクリューを用いて同様の
整復、固定を行った。
As both controls, the same reduction and fixing were carried out using rods and screws of the same diameter and the same length consisting of PLLA alone.

【0029】その後、25ケ月を経過した後、各々を屠
殺して、ロッド孔とスクリュー孔を観察したところ、コ
ントロールのロッドはPLLAが分解、吸収され、固体
としての残存は認められなかったが、ロッド孔は明瞭に
認められ、新生骨が置換するまでには至らなかった。ま
た、スクリューの場合は、約5〜30%のPLLAの固
体の残存があり、その分子量は2000〜3000以下
に劣化しているもののスクリュー孔は明瞭に認められ
た。
After the lapse of 25 months, each was sacrificed and the rod hole and the screw hole were observed. As a result, PLLA was decomposed and absorbed by the control rod, and no residual solid was observed. The rod hole was clearly visible and did not reach the point where the new bone was replaced. In the case of the screw, about 5 to 30% of PLLA solid remained, and although the molecular weight was degraded to 2000 to 3000 or less, screw holes were clearly recognized.

【0030】これに対し、HAを芯材に有するサンプル
1の複合ロッドの場合は、HA周囲のPLLAが分解、
吸収により消滅しており、その部分は新生骨で充填され
て、ロッド孔が残存していなかった。また、バイオアク
ティブな芯材を有するサンプル2のスクリューの場合
も、一部のPLLAが多孔質な状態で残存しているにも
かかわらず、バイオアクティブな効果により外周のPL
LAの一部は新生骨で旺盛に置換されており、スクリュ
ーの外孔はかなり充填された状態にあった。
On the other hand, in the case of the composite rod of Sample 1 having HA as a core material, PLLA around HA is decomposed,
It disappeared by resorption, and the portion was filled with new bone, and no rod hole remained. Also, in the case of the screw of sample 2 having a bioactive core material, even though a part of PLLA remains in a porous state, the PLA on the outer periphery is formed by the bioactive effect.
A portion of LA was vigorously replaced with new bone, and the outer hole of the screw was fairly filled.

【0031】以上の事実からして、骨接合用のデバイス
は本発明の目的を達成していることが裏付けられる。
The above facts confirm that the osteosynthesis device achieves the object of the present invention.

【0032】尚、術後の経過観察における軟X線像で
は、ロッド、スクリューの芯材によりX線観察が可能で
あった。また、4〜8週までの初期経過時点では骨切り
部に両側の骨折端から成長した充分な量の錯着仮骨およ
び橋状仮骨の完成が認められたが、これは延伸PLLA
の圧電性の効果によるものと考えられるので、ここにも
本発明の複合体よりなる骨接合用デバイスの意義があ
る。
Incidentally, in the soft X-ray image in the follow-up observation after the operation, X-ray observation was possible by the core material of the rod and the screw. In addition, at the initial stage from 4 to 8 weeks, a sufficient amount of the fused callus and the bridge-like callus grown from the fracture ends on both sides of the osteotomy were completed.
Therefore, the osteosynthesis device comprising the composite of the present invention also has significance here.

【0033】[0033]

【発明の効果】以上の説明から明らかなように、本発明
の骨接合用デバイスは、埋入直後においては表面が生体
内分解吸収性のPLA(PLLA)で被覆されており、
セラミックス系芯材の弾性率の高さによる周囲骨の強度
低下を緩和することができる。また、PLAの被覆材は
表面から徐々に分解吸収されるが、PLAのみからなる
デバイスに比べると総量が少ないために分解吸収は短期
間で完了し、吸収される絶対量も少ないため、炎症を起
こしたりする可能性は極めて低い。そして、この分解吸
収過程とその終焉時期に新生骨が空洞部分に薄く橋渡し
した状態となって埋まる状態となりやすいので、全てが
吸収性材料である場合に新生骨が完全に埋まる2〜3年
あるいは3〜4年の長期を要せず、短期間に新生骨で埋
まるという最大の利点を有する。
As is clear from the above description, the surface of the osteosynthesis device of the present invention is covered with PLA (PLLA) which is biodegradable and absorbable immediately after implantation.
It is possible to alleviate a decrease in the strength of the surrounding bone due to the high elastic modulus of the ceramic core material. In addition, the PLA coating material is gradually decomposed and absorbed from the surface, but the decomposition and absorption are completed in a short period of time because the total amount is smaller than that of the device composed of only PLA, and the absolute amount absorbed is small. Is very unlikely to occur. At the end of this decomposition and absorption process and at the end of the process, the new bone is likely to be buried in a state of bridging the cavity portion thinly. It has the greatest advantage of being filled with new bone in a short period of time without requiring a long period of 3 to 4 years.

【0034】また、被覆材料のPLAが完全に分解吸収
された後は、生体適合性に優れたセラミックス系の芯材
が、骨折及び損傷部位が完全に治癒するまでの間、骨接
合用デバイスとしての機能を果たす。そして、PLAの
被覆材が完全に吸収された時には、新生骨の発生により
骨折及び損傷部位の治癒がある程度進行しており、セラ
ミックス系デバイスの欠点である周囲骨の強度低下の現
象を最小限に抑えることができるという効果もある。
After the PLA of the coating material is completely decomposed and absorbed, a ceramic-based core material having excellent biocompatibility is used as an osteosynthesis device until the fracture and the damaged site are completely healed. Perform the function of When the PLA coating material is completely absorbed, the fracture and the healing of the damaged site have progressed to some extent due to the generation of new bone, and the phenomenon of strength reduction of the surrounding bone, which is a drawback of the ceramic device, is minimized. There is also an effect that it can be suppressed.

【0035】更に、セラミックス系の芯材がレントゲン
撮影時のマーカーになるので、PLAのみからなるデバ
イスがレントゲン撮影で写らないという欠点も解消でき
る。そして、被覆材料として用いる延伸したPLAは、
圧電効果により仮骨の生成を促進するという効果もあ
り、新生骨発生による治癒の促進が見られるものであ
る。
Furthermore, since the ceramic core material is used as a marker during radiography, the disadvantage that a device consisting of PLA alone cannot be photographed by radiography can be solved. And the stretched PLA used as the coating material is
There is also an effect of accelerating the generation of callus by the piezoelectric effect, and the healing is promoted by the generation of new bone.

【0036】このように、本発明の骨接合用デバイスは
極めて理想的なものである。
As described above, the osteosynthesis device of the present invention is extremely ideal.

フロントページの続き (56)参考文献 特表 平1−501289(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61L 25/00 - 31/00 A61B 17/58 Continuation of front page (56) References Table 1-501289 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61L 25/00-31/00 A61B 17/58

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 酸化物系セラミックスまたは燐酸カルシ
ウム系セラミックスの成形体を芯材とし、該芯材を一軸
延伸されたポリ乳酸で被覆したことを特徴とする骨接合
用デバイス。
An osteosynthesis device characterized in that a molded body of an oxide-based ceramic or a calcium phosphate-based ceramic is used as a core material, and the core material is coated with uniaxially stretched polylactic acid.
JP03341894A 1991-11-29 1991-11-29 Osteosynthesis device Expired - Fee Related JP3074410B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03341894A JP3074410B2 (en) 1991-11-29 1991-11-29 Osteosynthesis device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03341894A JP3074410B2 (en) 1991-11-29 1991-11-29 Osteosynthesis device

Publications (2)

Publication Number Publication Date
JPH05146501A JPH05146501A (en) 1993-06-15
JP3074410B2 true JP3074410B2 (en) 2000-08-07

Family

ID=18349567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03341894A Expired - Fee Related JP3074410B2 (en) 1991-11-29 1991-11-29 Osteosynthesis device

Country Status (1)

Country Link
JP (1) JP3074410B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108578787A (en) * 2018-08-07 2018-09-28 宁波宝亭生物科技有限公司 A kind of absorbable bone anchoring device and preparation method thereof

Also Published As

Publication number Publication date
JPH05146501A (en) 1993-06-15

Similar Documents

Publication Publication Date Title
EP0854734B1 (en) Under tissue conditions degradable material and a method for its manufacturing
EP0491983B1 (en) Biodegradable and resorbable molded article for surgical use
Törmälä Biodegradable self-reinforced composite materials; manufacturing structure and mechanical properties
KR102504497B1 (en) Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
Hope et al. Biodegradable pin fixation of elbow fractures in children. A randomised trial
FI81498B (en) SURGICAL MATERIAL OCH INSTRUMENT.
Bessho et al. A bioabsorbable poly-L-lactide miniplate and screw system for osteosynthesis in oral and maxillofacial surgery
FI120963B (en) Bioabsorbable elongated organ
Rokkanen Absorbable materials in orthopaedic surgery
Suuronen et al. Update on bioresorbable plates in maxillofacial surgery
JPH0363901B2 (en)
JP2002505142A (en) Biocompatible deformable fixation plate
Kumta et al. Absorbable intramedullary implants for hand fractures. Animal experiments and clinical trial
WO1996009014A9 (en) Composite threaded component and method of manufacture
Majola et al. Intramedullary fixation of cortical bone osteotomies with self-reinforced polylactic rods in rabbits
Törmälä Ultra-high strength, self-reinforced absorbable polymeric composites for applications in different disciplines of surgery
JP3010279B2 (en) Osteosynthesis device
JP3074410B2 (en) Osteosynthesis device
Tunc Orientruded polylactide based body-absorbable osteosynthesis devices: A short review
Vatchha et al. Biodegradable implants in orthopaedics
JPH09173435A (en) Implant material and its manufacture
JP3023470B2 (en) Method for producing osteosynthesis material having through holes
WO2020029502A1 (en) Absorbable bone fixation device and preparation method thereof
JPH07328109A (en) Device for osteosynthesis
Gutwald et al. Is there a need for resorbable implants or bone substitutes?

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000411

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080609

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090609

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees